Dr. Mayes graduated from Eastern Virginia Medical School and was trained in Internal Medicine and Rheumatology at the Cleveland Clinic. She was trained in Epidemiology at the University of Michigan School of Public Health. She came from Wayne State University in Detroit where she was Professor of Medicine, to join the UT faculty in 2002 and subsequently established the Scleroderma Clinic. Dr. Mayes is the recipient of many distinctions, awards and grants for the study and treatment of scleroderma. She is the author of 119 published manuscripts, 19 reviews, 6 book chapters and 1 full length book. Her clinical interests include the treatment of scleroderma and its multiple complications. She participates in several multi-center, national trials of new agents for this disease. Her research interests include the identification of susceptibility genes and disease activity genes in scleroderma and related autoimmune diseases. She has been named as a “Super Doc” by Texas Monthly magazine and “Best Doctors in America” since 2008. She is currently the Principal Investigator of the NIH/NIAMS funded Genome-Wide Association Study in Systemic Sclerosis ,’ that has the objective of identifying genes that influence disease susceptibility and severity; and PI of the the Scleroderma Family Registry and DNA Repository which serves as a national resource to supply genetic material to other investigators to study this disease. Dr. Mayes is the current the Director of the Centers of Research Translation in Scleroderma one of the longest continually funded research center of its kind in the US.